MCM
RVMD icon

MAI Capital Management’s Revolution Medicines RVMD Stock Holding History

MAI Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964K Buy
5,147
+1,326
+35% +$194K ﹤0.01% 990
2026
Q1 		$372K Buy
3,821
+195
+5% +$19.7K ﹤0.01% 1155
2025
Q4 		$289K Sell
3,626
-2,000
-36% -$131K ﹤0.01% 1165
2025
Q3 		$263K Hold
5,626
– – ﹤0.01% 1157
2025
Q2 		$207K Hold
5,626
– – ﹤0.01% 1160
2025
Q1 		$199K Hold
5,626
– – ﹤0.01% 1121
2024
Q4 		$246K Buy
+5,626
New +$284K ﹤0.01% 1063

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

MAI Capital Management's RVMD Position: Q2 2026 in Review

MAI Capital Management increased its Revolution Medicines (RVMD) stake by 35% in Q2 2026, buying an estimated $194K and bringing the position to 5,147 shares worth $964K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

MAI Capital Management first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • MAI Capital Management held 5,147 shares of Revolution Medicines worth $964K as of Q2 2026.
  • MAI Capital Management bought 1,326 Revolution Medicines shares in Q2 2026, an estimated $194K.
  • Revolution Medicines made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #990 holding.
  • MAI Capital Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.